Mov Disord Vol 31, Suppl 2 Archives - Page 71 of 207 - MDS Abstracts

2016 International Congress
Treatment of OFF episodes in Parkinson’s disease: An evaluation of patient and caregiver insights
E.J. Pappert, N. deGruyther, A. Agro (Toronto, ON, Canada)
Objective: Evaluate patient and caregiver opinions into the treatment of OFF episodes in patients with Parkinson's disease (PD). Background: OFF episodes are fairly common in…
2016 International Congress
Synaptic homeostasis in Parkinson’s disease: An high-density EEG study in different stage of the disease
S. Galati, S. Sarasso, C. Moeller, A. Kalein-Lang, C. Staedler (Lugano, Switzerland)
Objective: In order to corroborate these findings, we submitted 29 Parkinson's disease (PD) patients with different stage of disease to an all-night high-density EEG (hd-EEG)…
2016 International Congress
Detailed proteomic analysis of early PD brain highlights altered expression of mitochondrial proteins as an important event in sporadic PD
S. Gandhi, C.E. Murray, W.E. Heywood, J.L. Holton, K. Mills, T. Revesz (London, United Kingdom)
Objective: To uncover early pathogenic events occurring prior to neuronal loss and Lewy body formation in human PD brain. Background: In PD, pathological changes spread…
2016 International Congress
Lrrk2 alleles modify host response to microbial infections
B. Shutinoski, I. Harmsen, M. Hakimi, Y.Y. Zhou, S. Sad, J.J. Tomlinson, E.G. Brown, M.G. Schlossmacher, CLINT Investigators (Ottawa, ON, Canada)
Objective: The mechanisms by which allelic changes in LRRK2 modulate the susceptibility to Parkinson's disease, Crohn's disease and leprosy remain unknown. We hypothesized that leucine-rich…
2016 International Congress
Incidental finding of drug-induced movement disorder
G. Avagyan, H. Manvelyan, A. Nazaryan (Yerevan, Armenia)
Objective: Recognizing a drug-induced movement disorder is critical as only stopping using over the counter dopamine-blocking medications such as metoclopramide can reverse or improve clinical…
2016 International Congress
Alcohol-responsive action myoclonus of the leg in prostate cancer: A novel paraneoplastic syndrome
P. Termsarasab, S.J. Frucht (New York, NY, USA)
Objective: To describe two patients with prostate cancer and identical phenotypes of likely paraneoplastic unilateral leg myoclonus. Background: Paraneoplastic movement disorders (PMDs) in prostate cancer…
2016 International Congress
Sleep related disorders in subtypes of patients with Parkinson’s disease in the Tomsk region, Russia
M.A. Nikitina, I.A. Zhukova, V.M. Alifirova, N.G. Zhukova, O.P. Izhboldina, J.S. Mironova, M.A. Titova, N.G. Brazovskaya, S.E. Sukhanov (Tomsk, Russia)
Objective: To describe sleep related disorders (SRD) in Tremor Dominant (TD) and Akinetic Rigid (AR) patients with Parkinson's disease in (PwPD) subtypes evaluated at Movement…
2016 International Congress
A pilot study of SD-809 (deutetrabenazine) in tics associated with Tourette syndrome
J. Jankovic, J. Jimenez-Shahed, C. Budman, B. Coffey, T.K. Murphy, D. Shprecher, D. Stamler (Houston, TX, USA)
Objective: This study explored the safety, tolerability and preliminary efficacy of SD-809 (deutetrabenazine) in adolescents with moderate to severe tics associated with Tourette syndrome (TS).…
2016 International Congress
Correlation between tremor severity of essential tremor and perpendicular displacement in digital spiral analysis
K.H. Chen, Y.J. Chen, P.C. Lin, B.S. Yang, C.H. Lin, R.M. Wu (Hsin-Chu, Taiwan)
Objective: Using changes of perpendicular displacement in digital spiral drawing to evaluate the handwriting severity in essential tremor patients. Background: Essential tremor patients usually have…
2016 International Congress
Phenotypes in Essential Tremor: Gait analysis and imaging study
E. Boutin, T. Witjas, R. Carron, J. Regis, E. Guedj, J.P. Azulay, M. Vaugoyeau (Marseille, France)
Objective: If essential tremor (ET) is the most common movement disorder in adults, its pathophysiology remains poorly understood and few data are available as for…